Blood Drug Testing - Niacin Drug Test News

Niacin Drug Test News

Woman Struggles to Control Cholesterol Monday, July 11, 2011 @ 4:32AMTUESDAY, Dec. 28 (HealthDay News) -- Sheri Foote has cholesterol problems the likes of which few will ever have.
EMA CHMP recommends approval of linagliptin for type 2 diabetes Friday, June 24, 2011 @ 11:04AMBoehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.
ESC publishes position paper to raise the profile of vulnerable plaques Wednesday, June 15, 2011 @ 4:54AMThe European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.
Solana Health’s New Report Shows How to Lower Cholesterol Safely and Naturally for Adults, Teens, & Children Tuesday, May 31, 2011 @ 4:00PMSolana Health’s revealing How to Lower Cholesterol Naturally So You Can Live the Long, Happy Life You Deserve is a just-released free wellness report that details a 7-step approach for lowering LDL cholesterol and raising HDL cholesterol without prescription medication.
Five Lessons From Niaspan's Disappointing Study Tuesday, May 31, 2011 @ 6:41AMComparative effectiveness research -- investigations that determine which treatments are best -- has attracted attention in the health care debate. Critics charge that these studies are designed to restrict choice. The Center for Medicine in the Public Interest released a report that suggested that they would stifle innovation. Often they [...]
Study: 'Good' Cholesterol-Boosting Drug Fails to Reduce Heart Attacks, Strokes Friday, May 27, 2011 @ 7:45PMListen to the Audio JEFFREY BROWN: Next, the latest findings about how cholesterol drugs do and do not work. Margaret Warner has the story. MARGARET WARNER: Millions of Americans take two kinds of cholesterol drugs to lower their risk of heart attack or stroke, statins to reduce so-called bad cholesterol, and another class to boost so-called good cholesterol, known as HDL. But, yesterday ...
Cholesterol Drug Clinical Trial Halted, No Cardiovascular Benefits Friday, May 27, 2011 @ 4:47PMA clinical trial of a blood lipid treatment involving niacin, or vitamin B3, has been stopped 18 months early because it did not reduce the risk of cardiovascular events like strokes and heart attacks.
Interim analysis of AIM-HIGH study affirms positive impact of Niaspan on HDL and triglyceride lipid values Friday, May 27, 2011 @ 11:00AMThe National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), today disclosed results from an interim analysis of the AIM-HIGH clinical trial.
A.M. Vitals: Abbott’s Niaspan Setback May Reverberate With Merck Friday, May 27, 2011 @ 7:57AMAlso: combining military and VA electronic health records; HIV treatment irony; inadvertent TB exposure at Emory.
Study: Boosting 'good' cholesterol useless Friday, May 27, 2011 @ 4:50AMBoosting "good" cholesterol does not protect against heart attacks and strokes, according to a study that was abruptly stopped when the outcome became clear, officials said Thursday.
High hopes for 'good' cholesterol are dashed Friday, May 27, 2011 @ 12:21AMWASHINGTON - Boosting "good" cholesterol does not protect against heart attacks and strokes, according to an eagerly awaited study that was abruptly stopped when the outcome became clear, officials said Thursday.
Stroke drug study a letdown Thursday, May 26, 2011 @ 11:45PMThe federally funded study of more than 3,400 U.S. adults at high risk for heart attacks and strokes was halted 18 months early after researchers realized that the drug niacin failed to cut the risk -- as was hoped and suggested by many earlier, smaller studies, officials said. [...] niacin appeared to increase study participants' risk for one particular type of stroke. The findings are a major ...
Study: Boosting Good Cholesterol With Niacin Did Not Cut Heart Risks Thursday, May 26, 2011 @ 12:49PMA federal study testing prescription-strength niacin as an add-on to cholesterol-lowering statins to prevent heart disease was stopped early because the niacin did not work. There was also a slight increase in stroke risk for people taking the prescription-strength niacin. read more
Abbott Statement on Interim Study Results of AIM-HIGH Thursday, May 26, 2011 @ 12:39PMABBOTT PARK, Ill., May 26, 2011 /PRNewswire/ -- The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), today disclosed results from an interim analysis of the AIM-HIGH clinical trial. AIM-HIGH was designed to test whether raising HDL and lowering triglycerides in a patient population with established cardiovascular disease and very well ...
HDL-Raising Drug Fails To Show Benefit In Government Study Thursday, May 26, 2011 @ 11:01AMThe National Heart Lung and Blood Institute stopped a large clinical trial of prescription niacin, which raises high density lipoprotein, the "good cholesterol," because the drug failed to prevent heart attacks and strokes.
Beauty board: We test a dozen of the latest sunscreens Wednesday, May 18, 2011 @ 1:55PMIt's time for some summer fun, and that means lots of sun exposure. Protection is key, but the sheer number of sunscreens on the market is enough to make you see red. To help, we tested a dozen lotions, sprays and creams, from SPF 30 up to 100.
Boy's Drink Spiked With Niacin At Avonworth HS Friday, May 6, 2011 @ 4:39PMA student gets a scare when his drink is spiked, but later finds out it wasnt illegal drugs.
Amylin's new metreleptin data in lipodystrophy to be presented at AACE meeting Saturday, April 16, 2011 @ 1:10AMAmylin Pharmaceuticals, Inc. today announced results from a new analysis of an ongoing, long-term research study of the investigational drug metreleptin, an analog of the human hormone leptin, for the treatment of lipodystrophy.
Prepared Patient: Vitamins & Supplements, Before You Dive In Wednesday, April 6, 2011 @ 3:22AMVitamins, herbs and other dietary supplements are sold as natural alternatives to pharmaceuticals and many people turn to them in an attempt to improve their health. Others seek supplements to lose weight or after hearing that they can help with serious medical conditions. These products are now used at least monthly by more than half of all Americans and their production, marketing and sales ...
Vitamins & Supplements: What You Need to Know Before You Dive In Tuesday, April 5, 2011 @ 3:30PMWhat Are Dietary Supplements and How Are They Regulated? April 5, 2011 - Vitamins, herbs and other dietary supplements are sold as natural alternatives to pharmaceuticals and many people turn to them in an attempt to improve their health.
Prepared Patient: Vitamins & Supplements: Before You Dive In Tuesday, April 5, 2011 @ 2:42PMVitamins, herbs and other dietary supplements keep rising in popularity among U.S. health seekers. But are they safe?
Reverse Medical's ReFlex A+ Catheter receives European CE mark approval Tuesday, April 5, 2011 @ 6:09AMReverse Medical Corporation announced today that it has received CE Mark for its ReFlex A+ Catheter for intracranial distal access, delivery and aspiration.
Healthy cholesterol can boost memory Tuesday, March 22, 2011 @ 12:06AMWant to be able blow out the candles on your 100th birthday cake and actually remember what you did during all of those years? Then keep your healthy HDL cholesterol high.
How good cholesterol can keep Alzheimer's away Saturday, March 19, 2011 @ 7:15PMDr. Mehment Oz, Michael Roizen Special to The Washington Examiner Want to be able blow the candles out on your 100th birthday cake and actually remember what you did during all of those years? Then keep your healthy HDL cholesterol high. That's a secret shared by long-lived people who've never developed memory-robbing Alzheimer's disease: They have higher-than-average HDL levels. Participants in ...
Drug reduces gum disease, risk of osteoporosis, heart disease in women Thursday, March 10, 2011 @ 9:05AM(PhysOrg.com) -- New research has shown that a federally approved pharmaceutical for treating periodontal disease also significantly reduces risk of osteoporosis and cardiovascular disease in postmenopausal women.
Middle-age people with cardiovascular issues may have increased risk of developing early memory problems Monday, February 21, 2011 @ 11:17PMMiddle-age men and women who have cardiovascular issues, such as high cholesterol and high blood pressure, may not only be at risk for heart disease, but for an increased risk of developing early cognitive and memory problems as well.
Cholesterol: The good, the bad, the unknown Monday, February 21, 2011 @ 4:40PMTwo people are diagnosed with high cholesterol, one of the leading risk factors for heart disease, and follow similar therapies. One ends up with improved cholesterol levels, but the other doesn't.
Imaging specialists see cardiovascular disease before it turns critical Tuesday, December 28, 2010 @ 5:38PMCardiovascular disease (CVD), also known as heart disease, is the leading cause of death for both men and women in the United States. More than 81 million Americans are living with the disease.
Woman Struggles to Control Cholesterol Tuesday, December 28, 2010 @ 11:02AMTUESDAY, Dec. 28 (HealthDay News) -- Sheri Foote has cholesterol problems the likes of which few will ever have.
Inside a woman’s heart ... Saturday, December 4, 2010 @ 5:15PMThere are many risk factors that increase the chances of heart disease in women.
Cholesterol drug breakthrough Wednesday, November 17, 2010 @ 11:27PMAn experimental drug dramatically raised good HDL cholesterol, but before it gets on the market, researchers first must be sure that doing so saves.
Experimental Pill For 'Good' Cholesterol Shines In Safety Study Wednesday, November 17, 2010 @ 5:01PMA daily pill from Merck raised HDL cholesterol by 138 percent in people who got the medicine compared with those who didn't. The pill, which hasn't been approved by the Food and Drug Administration, also cut bad cholesterol by 38 percent. read more
Experimental Pill For 'Good' Cholesterol Shines In Safety Study Wednesday, November 17, 2010 @ 3:33PMA daily pill from Merck raised HDL cholesterol by 138 percent in people who got the medicine compared with those who didn't. The pill, which hasn't been approved by the Food and Drug Administration, also cut bad cholesterol by 38 percent.
New drug bumps up good cholesterol Wednesday, November 17, 2010 @ 2:38PMAnacetrapib lowers the bad stuff, too, new test indicates
Drug raises good cholesterol but needs review Wednesday, November 17, 2010 @ 11:18AMAn experimental drug dramatically raised good HDL cholesterol, but before it gets on the market researchers first must be sure that doing so saves lives rather than takes them, as a similar drug did several years ago.
With the determination of a military man, Monday, November 8, 2010 @ 8:02PMIf there is one passion in Frank Hedy's life, it is tennis.Hedy came to love the game when he
Acura Pharmaceuticals Reports 3rd Qtr 2010 Financial Results and Product Development Update Tuesday, November 2, 2010 @ 4:38PMPALATINE, Ill. -- Acura Pharmaceuticals, Inc. today reported a third quarter 2010 net loss of $2.6 million or $0.05 per share compared to net loss of $4.0 million, or $0.09 per share for the third quarter of 2009.
Study explains statistical link between low aerobic exercise capacity and common diseases Tuesday, November 2, 2010 @ 5:14AMEverybody knows that if you're physically fit, you're less likely to get a wide range of diseases. What most people don't know is that some people are "naturally" in better shape than others, and this variation in conditioning makes it difficult to test for disease risk and drug effectiveness in animal models.
Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV Tuesday, October 26, 2010 @ 12:00AMVertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the ...
Myrexis releases MPC-9528 cancer metabolism inhibitor preclinical study results Monday, September 20, 2010 @ 6:14AMMyrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced key findings from preclinical studies of the Company's novel cancer metabolism inhibitor (CMI), MPC-9528, at the Cancer and Metabolism Pathways to the Future Symposium in Edinburgh, Scotland.
Hallucinogen Shows Promise In Helping Cancer Patients Cope Tuesday, September 7, 2010 @ 12:52PMA small study of the active ingredient in "magic mushroom" found the drug helped relieve anxiety and improve the mood of some patients with advanced cancer. Though preliminary, the results support further research, the scientists say. read more
Hallucinogen Shows Promise In Helping Cancer Patients Cope Tuesday, September 7, 2010 @ 11:40AMA small study of the active ingredient in "magic mushroom" found the drug helped relieve anxiety and improve the mood of some patients with advanced cancer. Though preliminary, the results support further research, the scientists say.
US researchers test magic mushrooms on cancer patients Monday, September 6, 2010 @ 8:21PMThe hallucinogen psilocybin - known by the street name magic mushrooms - may help ease the anxiety that often accompanies late-stage cancer
Acura Pharmaceuticals Reports Second Quarter 2010 Financial Results Thursday, July 29, 2010 @ 3:05PMPALATINE, Ill. -- Acura Pharmaceuticals, Inc. today reported a second quarter 2010 net loss of $3.2 million or $0.07 per share compared to net loss of $6.5 million, or $0.14 per share for the second quarter of 2009.
Higher 'good' cholesterol linked to lower cancer risk Monday, June 14, 2010 @ 4:01PMPeople who have low levels of the so-called good cholesterol have long been known to be at higher risk of heart attacks and heart disease. Now, a new study suggests they may have a higher risk of cancer, too.
TV food advertisements promote imbalanced diets, study finds Tuesday, June 1, 2010 @ 10:26PMMaking food choices based on television advertising results in a very imbalanced diet, according to a new study comparing the nutritional content of food choices influenced by television to nutritional guidelines.
TV Food Advertisements Promote Imbalanced Diets Tuesday, June 1, 2010 @ 8:12AMMaking food choices based on television advertising results in a very imbalanced diet according to a new study comparing the nutritional content of food choices influenced by television to nutritional guidelines published in the June issue of the Journal of the American Dietetic Association. Investigators found that a 2,000-calorie diet consisting entirely of advertised foods would contain 25 ...
TV food advertisements promote imbalanced diets Monday, May 31, 2010 @ 11:24PM( Elsevier Health Sciences ) Making food choices based on television advertising results in a very imbalanced diet according to a new study comparing the nutritional content of food choices influenced by television to nutritional guidelines published in the June issue of the Journal of the American Dietetic Association.
Niacin fortification foods can cause obesity Thursday, May 20, 2010 @ 11:54PMDietary factors have long been known to play a major role in the development of obesity. The global increasing prevalence of obesity suggests that there should be some common changes in diet worldwide.
Biotech Stocks: Acura tanks; Bayer, Onyx gain on rival's study Friday, April 23, 2010 @ 9:51AMAcura Pharmaceuticals is the sharpest decliner among the small-cap drug stocks in early activity, with shares plunging on a negative FDA decision on its new painkiller Acurox.